Director of Bioinformatics, William Harvey Research Institute, QMUL, London.
Dr Michael Barnes has over 14 years of Pharma R&D experience and was recently appointed Director of Bioinformatics at the William Harvey Research Institute, Queen Mary University of London. He previously led a computational biology team at GlaxoSmithKline focused on translational research for neuroscience drug discovery. After leaving GSK, he co-founded OI Pharma Partners, with Dr Jackie Hunter (www.oipharma.com). The company advocates the use of open innovation as a tool to stimulate R&D in the pharma and healthcare sectors. This work continues alongside his main focus of research on the use of genomic data to for drug discovery and better patient stratification. Michael has consistently championed pre-competitive collaboration and partnership between industry and academia. He co-led the original EFPIA team to propose the Open PHACTS project and continues to take a close interest in the project now from an academic perspective. Now working both in academia and biotech he is working hard to better understand and enhance the collaborative interface between the two sectors, towards the ultimate goal of clinical translation.